Recently a study was conducted at the Medical College of Georgia at Augusta University. The study involved a two week regimen of CBD being given to mice. Long story short, promising evidence was obtained supporting that CBD can help with symptoms on early patients. 

Alzheimer’s disease is the result of dead cells, plaque and other debris piling up into key places in the patients brain. The cause of this is a lack of proteins that get rid of these unwanted compounds. The two specific proteins needed are IL-33 and TREM2. This study showed that CBD was able to normalize IL-33 levels while reducing IL-6, another unwanted protein that increases inflammation. 

In other cases, CBD was found to raise levels on IL-33 and TREM2 to levels seven fold what was found before the study began. Some of these studies involved motor ability was also improved. 

The experts involved in the study claim that CBD helps to signal the body that there are unwanted elements in the brain that need to be addressed. In the case of TREM2, its primary objective is to activate these immune cells when viruses or damaged neurons are detected. CBD helps to combine this protein with with other proteins that signal immune cells. 

There are some other ways that CBD was found to help Alzheimer’s. The first way was by reducing the oxygen buildup. Another was by reducing inflammation, common problem among Alzheimer’s and dementia patients. Lastly, by acting as a neuro protectant and brain stimulant once the plaque is removed via IL-33 and TREM2. It is also proved that CBD effectively reduces stress and anxiety in the user. People with dementia often have high anxiety levels and the use of CBD helps in reducing it.

The results suggest that early onset Alzheimer’s can be treated with doses of CBD oil. Later stages, on the other hand, are not addressed. Doses were given every two days. While doses vary based on the recipient, the doses were said to be high. 

The study also explored the potential for CBD to be administered with an inhaler. This would allow for quick access to the brain. The mice in the study were given oral doses.

Like many aspects of the cannabis industry, more research is needed. Never the less, the findings paved the way for a potential solution to a disease that currently doesn’t have an absolute cure.